COVID-19

The COVID-19 public health emergency is particularly challenging for people in treatment for substance use disorder, people in recovery, and people who use drugs. This collection features educational resources that can be adapted for local settings, specific guidance on harm reduction, recovery housing and providing peer support services during the pandemic, and links to websites that provide high-quality information, data, and/or examples for local communities to adopt.

Featured Collection

Rethink Rx Abuse Strategy 5: Enhance Assessment and Referral to Substance Use Disorder Treatment

Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities improve patient assessment and referral to substance use disorder treatment. Includes information about medication assisted treatment for opioid use disorder, screening, brief intervention and referral to treatment (SBIRT), fact sheets on identifying opioid use disorder (OUD) or people at risk for developing OUD, and a guide to finding behavioral health treatment services.

Featured Collection
Policymakers & Community Leaders
Payers & Providers
Patients & Caregivers

The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue

Source: Substance Abuse and Mental Health Services Administration

This report details how the opioid crisis has affected the Hispanic/Latino population in the US. It includes data on opioid use in this community and a discussion of the socio-cultural factors associated with accessing services including facilitators and barriers to accessing appropriate prevention, treatment, and recovery services and supports.

Document
Policymakers & Community Leaders
Payers & Providers
Patients & Caregivers

Federal Grantees May Now Use Funds to Purchase Fentanyl Test Strips

Source: Substance Abuse and Mental Health Services Administration

The Substance Abuse and Mental Health Services Administration and the Centers for Disease Control and Prevention announced that federal funding may be used to purchase rapid fentanyl test strips (FTS). FTS can be used to determine if drugs have been cut or mixed with fentanyl which greatly increases the risk of overdose death.

External Website
Policymakers & Community Leaders
Payers & Providers
Patients & Caregivers

Approval of Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose

Source: U.S. Food and Drug Administration

In April 2021, the FDA announced approval of an application for a produce to deliver an 8 milligram (mg) dose of naloxone; previous approvals had been granted for products delivering 2 mg and 4 mg of naloxone. The approval was granted to provide an additional option for the treatment of opioid overdose.

External Website
Policymakers & Community Leaders
Payers & Providers

Medicaid Delivery System Reforms to Combat the Opioid Crisis

Source: Academy Health and the Milbank Memorial Fund

This report provides an overview of Medicaid delivery system reform efforts aimed at addressing the opioid crisis. The report describe 2 models of delivery system reforms: adoption of the Medicaid health home model for opioid use disorder (OUD) treatment and innovations that improve warm handoffs and care transitions from different levels of substance use disorder treatment.

Document